TIPS for refractory ascites: a single-centre experience

J Gastroenterol. 2009;44(10):1089-95. doi: 10.1007/s00535-009-0099-6. Epub 2009 Jul 2.

Abstract

Purpose: Transjugular intrahepatic portosystemic shunt (TIPS) has been reported superior to large-volume paracentesis for refractory ascites, but post-TIPS encephalopathy is a major complication. We intended to assess the outcome of limited diameter TIPS on ascites control, mortality, and encephalopathy in patients with refractory ascites at our centre.

Methods: TIPS was successfully performed on 56 patients. Initial stent dilatation was to 6 mm, if there was a reduction in portal pressure gradient (PPG) >25%, further dilatation was not proposed.

Results: Either complete or partial response was obtained in 58%, 81%, 83%, and 93% of patients at 1, 3, 6, and 12 months, respectively. Mortality was 10%, 29%, 37%, and 50% at 1, 3, 6, and 12 months, respectively. In 27 patients (48%), a new episode of encephalopathy developed, but only 6 (22%) were grade III or IV and 23 (85%) responded quickly to treatment.

Conclusions: The results of our study confirm the efficacy of TIPS for refractory ascites. The use of narrow-diameter dilatation without aiming at lowering the PPG below a certain threshold might simplify the procedure and the follow-up for these patients.

MeSH terms

  • Ascites / etiology
  • Ascites / mortality
  • Ascites / prevention & control
  • Ascites / surgery*
  • Dilatation / instrumentation
  • Dilatation / methods*
  • Esophageal and Gastric Varices / epidemiology
  • Female
  • Follow-Up Studies
  • Hepatic Encephalopathy / epidemiology
  • Hepatic Encephalopathy / etiology*
  • Humans
  • Hypertension, Portal / epidemiology
  • Liver Diseases / complications
  • Liver Diseases / mortality
  • Liver Diseases / surgery
  • Male
  • Middle Aged
  • Paracentesis
  • Portasystemic Shunt, Transjugular Intrahepatic* / adverse effects
  • Portasystemic Shunt, Transjugular Intrahepatic* / methods
  • Portasystemic Shunt, Transjugular Intrahepatic* / mortality
  • Prosthesis Failure
  • Recurrence
  • Retrospective Studies
  • Severity of Illness Index
  • Stents*
  • Survival Rate
  • Treatment Outcome